Steve Miller - Aug 20, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Stock symbol
CPRX
Transactions as of
Aug 20, 2024
Transactions value $
-$3,052,900
Form type
4
Date filed
8/22/2024, 05:00 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale -$1.01M -50K -6.06% $20.26 775K Aug 20, 2024 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Sale -$1.01M -50K -6.45% $20.21 725K Aug 20, 2024 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Sale -$1.03M -50K -6.9% $20.59 675K Aug 20, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Shares were sold in various lots from $20.12 to $20.525 per share. The price listed represents a weighted average price for the shares sold.
F3 Shares were sold in various lots from $20.12 to $20.49 per share. The price listed represents a weighted average price for the shares sold.
F4 Shares were sold in various lots from $20.325 to $20.71 per share. The price listed represents a weighted average price for the shares sold.